Monday, June 28, 2021

PharmEasy gets $300 million booster shot for Thyrocare deal

PharmEasy has raised $300 million more, bringing the total funding received by the online pharmacy since April to $650 million, most of which will be used to fund its ongoing acquisition of diagnostics chain Thyrocare.

from Tech-Economic Times https://ift.tt/3Afitz4
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Softbank Group launches over $10 billion in bonds for OpenAI investment, term sheet shows

The dollar-denominated notes are split into 3-1/2-year, 5-1/2-year and 7-1/2-year tenors, while the euro-denominated bonds are split into 4-...